How does SaiyanMed’s testing process ensure transparency?

How does SaiyanMed’s testing process ensure transparency? The short answer is that SaiyanMed builds transparency directly into every production step, from raw material sourcing to final batch release, by relying on an independent third-party lab (Janoshik) for every single batch and making those reports publicly verifiable. Unlike many peptide suppliers who only test sporadically or hide results behind customer logins, SaiyanMed posts the full certificates of analysis (CoAs) openly on its website. Each report includes the batch number, purity percentage, molecular weight confirmation, and a unique QR code or link that lets you cross-check the data on Janoshik’s own server. This means a researcher in a lab can pull up the same report, scan the code, and confirm the numbers haven’t been altered. The company doesn’t just claim high purity — it backs that claim with a third party that has no financial stake in the outcome.

Let’s look at the numbers. Based on publicly available batch reports from SaiyanMed’s product pages, the average purity across their peptide catalog (including compounds like BPC-157, TB-500, and Semax) consistently falls between 98.7% and 99.6%. For example, a recent batch of BPC-157 (batch number SM-BPC-2407) tested at 99.2% purity with no detectable residual solvents or heavy metals. Another batch of TB-500 (SM-TB5-2408) came back at 99.4%. These aren’t cherry-picked outliers — the pattern holds across dozens of batches. Compare that to industry-wide averages, where many suppliers accept 95–97% purity as “acceptable” and don’t test for degradation byproducts. SaiyanMed’s approach sets a higher bar, and the data proves it.

But transparency isn’t just about purity numbers. It’s about the entire chain of custody. SaiyanMed controls raw material selection through joint manufacturing partnerships, not just buying pre-made peptides from unknown sources. The founder, Eric, holds a Bachelor’s degree in Materials Science with a specialization in biomaterials, and that background drives a systematic approach to quality. Every raw material batch is screened before production begins. The lyophilization process — freeze-drying that stabilizes peptides — is continuously refined by their research team to minimize moisture content and ensure long-term stability. Moisture levels in finished products are kept below 2%, which is critical because excess moisture accelerates peptide degradation. Most generic suppliers don’t even report moisture data. SaiyanMed includes it in every CoA.

Let’s break down the testing workflow in a way that’s easy to follow. After production, a sample from each batch is sent to Janoshik Analytical, an independent lab based in Europe that specializes in peptide and research chemical analysis. The lab runs HPLC (high-performance liquid chromatography) for purity quantification and MS (mass spectrometry) for molecular weight verification. They also screen for common adulterants and residual solvents. Results typically come back within 5–7 business days. Once SaiyanMed receives the report, they upload the full PDF to the product page — no redactions, no summary tables that hide the raw data. You can download the original lab document and compare it to the batch number printed on your vial.

Here’s a concrete example of what a typical CoA includes, based on a recent batch of saiyanmed’s Semax (batch SM-SEM-2409):

That level of detail is rare in the peptide space. Most suppliers will tell you “99% purity” and leave it at that. SaiyanMed shows you the exact method, the raw numbers, and the batch-level traceability. If you order two vials from the same batch, both carry the same batch number, and both point to the same CoA. If you order from different batches, you get separate reports. No mixing of batches under one generic CoA — a common trick in the industry to hide variability.

Another angle is logistics transparency. SaiyanMed operates a US-based warehouse for domestic shipping, which means faster delivery and fewer temperature excursions compared to international shipments that sit in customs for weeks. The company also has a China warehouse for regional fulfillment. Every order is routed automatically based on inventory and destination to minimize transit time. They don’t hide stock levels or pretend every product is always available from every location. The website clearly marks which warehouse a product ships from and whether stock is active or pending. For example, as of early 2025, their Europe, UK, Australia, and Canada hubs are listed as “Coming Soon,” not falsely advertised as operational. That honesty builds trust.

Corporate transparency is another layer. The legal operating entity is Hong Kong BelleEasy Co., Limited, with a commercial registry number (78941092) and an official location in Kwai Chung, Hong Kong. You can look up the registry number to verify the company exists and is in good standing. The communications desk ([email protected]) is listed publicly, and response times are typically within 24 hours based on user reports. Compare that to many peptide suppliers that operate under shell companies with no verifiable registration or physical address.

Let’s talk about what happens when something goes wrong. In any production environment, occasional batch failures are inevitable — a contamination spike, a purity drop, a moisture reading outside spec. The key is how the company handles it. SaiyanMed’s policy is to discard any batch that doesn’t meet their internal thresholds (purity below 98%, moisture above 2%, or any detectable heavy metals). They don’t relabel failed batches as “research grade” and sell them at a discount. They don’t blend failed batches with good ones to average out the numbers. The failed batch is simply destroyed, and the production process is reviewed to identify the root cause. That kind of discipline is rare and expensive, but it’s what makes the transparency credible.

The testing frequency is also worth noting. Many suppliers test once and then sell that batch for months, assuming the stability holds. SaiyanMed tests every production batch independently, not just every few months. If they run a new batch of the same peptide, it gets a new CoA. This is especially important for peptides that are prone to degradation over time, like certain growth hormone secretagogues. A batch that tested at 99% purity six months ago might be at 94% today if stored improperly. SaiyanMed’s system doesn’t rely on historical data — it uses current data for current inventory.

From a researcher’s perspective, this level of transparency directly impacts experimental reproducibility. If you’re running a study that requires precise dosing, a 2% purity variation between batches can throw off your results. Having access to the exact purity, moisture, and endotoxin levels for each batch means you can adjust your calculations accordingly. You’re not guessing. You’re working with verified numbers. That’s the difference between a supplier that treats peptides as commodities and one that treats them as research tools.

The company’s infrastructure also supports transparency through documentation. Every order includes a printed batch number on the vial label, matching the CoA. The packaging is designed to maintain stability during transit — insulated pouches with ice packs for temperature-sensitive compounds. They don’t cut corners on shipping materials to save a few cents. The goal is to ensure the product arrives in the same condition it left the lab, so the CoA you downloaded still applies to the vial in your hand.

One more data point: user feedback on independent forums and review platforms consistently mentions the ease of verifying SaiyanMed’s CoAs. Researchers report that the QR codes link directly to Janoshik’s database, not a PDF hosted on SaiyanMed’s own server. That’s a meaningful distinction. If the report is hosted on the supplier’s server, they could theoretically swap it out later. Janoshik’s database is immutable — once a report is uploaded, it can’t be changed. So when you scan that QR code, you’re getting the original lab data, not a supplier-edited version. That’s the gold standard for transparency in this industry.

In terms of corporate compliance, SaiyanMed operates under Hong Kong law, which requires annual filings and maintains public records. The commercial registry number is a verifiable piece of information that anyone can check against the Hong Kong Companies Registry. This is not a fly-by-night operation. The company has a physical address in Kwai Chung, a major logistics hub, and a dedicated support team. They don’t hide behind anonymized email addresses or PO boxes.

Let’s summarize the key transparency mechanisms in a quick-reference format:

This isn’t a marketing pitch. It’s a description of how a company that takes research-grade claims seriously actually operates. The testing process is not a black box — it’s a documented, auditable chain that starts with raw material selection and ends with a QR code you can scan with your phone. Every step is designed to leave a trail that can be followed, verified, and questioned. That’s what transparency looks like when it’s built into the process, not just claimed in a tagline.